muscimol has been researched along with homovanillic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamioka, T; Matsui, Y | 1 |
| James, TA; Straughan, DW | 1 |
| Haubrich, DR; Martin, GE | 1 |
| Trifunovic, R; Wirtshafter, D | 1 |
| Essig, EC; Kilpatrick, IC | 1 |
| Bendotti, C; Berettera, C; Invernizzi, R; Samanin, R | 1 |
| Moshé, SL; Sharpless, NS; Sperber, EF; Wurpel, JN | 1 |
| Asin, KE; Klitenick, MA; Wirtshafter, D | 1 |
| Blanchard, JC; Boireau, A; Garret, C; Julou, L; Stutzmann, JM | 1 |
| Amladi, SR; Kelkar, MR; Naik, SR; Sheth, UK | 1 |
| Fung, YK; Kuruvilla, A; Uretsky, NJ | 1 |
| Cano, J; Machado, A; Santiago, M | 1 |
| Ikemoto, S; Kohl, RR; McBride, WJ | 1 |
| Huston, JP; Petri, D; Pum, M; Schnitzler, A; Vesper, J | 1 |
| Czarnecka, A; Kamińska, K; Konieczny, J; Lenda, T; Nowak, P | 1 |
1 review(s) available for muscimol and homovanillic acid
| Article | Year |
|---|---|
Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
Topics: Amino Acids; Amino Acids, Cyclic; Animals; Brain Mapping; Cats; Corpus Striatum; Cyclohexanecarboxylic Acids; Dopamine; Electrophysiology; Ethanolamines; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Homovanillic Acid; Hydroxydopamines; Mice; Motor Activity; Muscimol; Neural Inhibition; Neural Pathways; Oxidopamine; Picrotoxin; Rats; Substantia Nigra | 1979 |
14 other study(ies) available for muscimol and homovanillic acid
| Article | Year |
|---|---|
Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines.
Topics: 4-Aminobutyrate Transaminase; Animals; Anti-Anxiety Agents; Benzodiazepines; Catalepsy; Corpus Striatum; Cyclohexanecarboxylic Acids; Cyclohexylamines; Drug Interactions; gamma-Aminobutyric Acid; Globus Pallidus; Haloperidol; Homovanillic Acid; Humans; Injections; Male; Muscimol; Oxazoles; Rats; Substantia Nigra; Transaminases | 1978 |
Striatal dopamine release and contraversive rotation elicited by intranigrally applied muscimol.
Topics: Animals; Behavior, Animal; Dopamine; Functional Laterality; Homovanillic Acid; Movement; Muscimol; Oxazoles; Substantia Nigra | 1978 |
Nonserotonergic control of nucleus accumbens dopamine metabolism by the median raphe nucleus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Fenclonine; Homovanillic Acid; Male; Muscimol; Nucleus Accumbens; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin | 1992 |
Haloperidol-induced increases in rat amygdaloid dopamine metabolism: evidence for independence from postsynaptic feedback mechanisms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Caudate Nucleus; Chromatography, High Pressure Liquid; Dopamine; Feedback; Haloperidol; Homovanillic Acid; Male; Microinjections; Muscimol; Putamen; Rats; Rats, Inbred Strains; Synapses | 1991 |
Selective involvement of dopamine in the nucleus accumbens in the feeding response elicited by muscimol injection in the nucleus raphe dorsalis of sated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Eating; Fluphenazine; Food Deprivation; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections; Male; Motor Activity; Muscimol; Nucleus Accumbens; Raphe Nuclei; Rats; Satiation; Septal Nuclei | 1986 |
Intranigral GABAergic drug effects on striatal dopamine activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Bicuculline; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Muscimol; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1989 |
Is dopamine involved in the hyperactivity produced by injections of muscimol into the median raphe nucleus?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Haloperidol; Hippocampus; Homovanillic Acid; Male; Motor Activity; Muscimol; Nucleus Accumbens; Organ Specificity; Raphe Nuclei; Rats; Rats, Inbred Strains; Reference Values; Serotonin | 1988 |
Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Binding, Competitive; Cats; Cerebellum; Chlordiazepoxide; Corpus Striatum; Cyclic GMP; Diazepam; Evoked Potentials; gamma-Aminobutyric Acid; Homovanillic Acid; In Vitro Techniques; Muscimol; Naphthyridines; Nitrazepam; Phenothiazines; Piperazines; Rats; Spinal Cord; Sulfur Compounds | 1984 |
Effect of muscimol, a central GABA receptor agonist, on the catalepsy, striatal homovanillic acid increase, and analgesia induced by pilocarpine in rats.
Topics: Analgesics; Animals; Catalepsy; Corpus Striatum; Drug Interactions; Homovanillic Acid; Humans; Male; Muscimol; Oxazoles; Phenylacetates; Pilocarpine; Rats; Rats, Inbred Strains | 1981 |
BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Muscimol; Oxazoles; Substance Withdrawal Syndrome | 1982 |
Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Dopamine; GABA-A Receptor Antagonists; GABA-B Receptor Antagonists; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Muscimol; Nomifensine; Picrotoxin; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B | 1993 |
GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bicuculline; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Female; GABA Agonists; GABA Antagonists; GABA-A Receptor Antagonists; Homovanillic Acid; Microdialysis; Microinjections; Muscimol; Nucleus Accumbens; Picrotoxin; Rats; Rats, Wistar; Self Administration; Ventral Tegmental Area | 1997 |
GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Animals; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Functional Laterality; GABA-A Receptor Agonists; Homovanillic Acid; Male; Medial Forebrain Bundle; Mental Disorders; Muscimol; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Receptors, GABA-A; Statistics, Nonparametric; Subthalamic Nucleus; Time Factors | 2013 |
Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Cell Count; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; GABA-A Receptor Agonists; Homovanillic Acid; Locomotion; Male; Muscimol; Neurons; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Rats, Wistar; Receptors, GABA-A; Substantia Nigra | 2015 |